Cargando…
Overview of recent developments in chronic lymphocytic leukemia
Multiple advances have been made in our understanding of pathobiology of chronic lymphocytic leukemia (CLL). These developments in the laboratory include new prognostic markers, risk stratification of the disease and newer therapeutic agents in CLL. These advances in CLL have come a long way in the...
Autores principales: | Jain, Preetesh, Rai, Kanti R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876608/ https://www.ncbi.nlm.nih.gov/pubmed/24455520 http://dx.doi.org/10.4103/2278-330X.103721 |
Ejemplares similares
-
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes
por: Sherry, Barbara, et al.
Publicado: (2015) -
Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia
por: Rai, Kanti R.
Publicado: (2015) -
Overview of non‐coding mutations in chronic lymphocytic leukemia
por: Spina, Valeria, et al.
Publicado: (2019) -
Recent therapeutic advances in chronic lymphocytic leukemia
por: Bose, Prithviraj, et al.
Publicado: (2017) -
Recent advances in chronic lymphocytic leukemia therapy
por: Uhm, Jieun
Publicado: (2020)